Skip to main content

Italian Dx Shop to Use Transgenomic's Wave Tech to Develop Heart Disease Assay

NEW YORK (GenomeWeb News) — Transgenomic today said that Italian molecular diagnostic shop Fiuotecnica will use its Wave technology to develop and market a genetic assay panel to predict the risk of cardiovascular disease and heart attacks.
 
Fiuotecnica will retain rights to market the panel in Italy and Transgenomic will obtain rights to market it in the rest of the world.
 
Financial terms of the agreement were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.